Rie Sakakibara

782 total citations
27 papers, 528 citations indexed

About

Rie Sakakibara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Rie Sakakibara has authored 27 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Rie Sakakibara's work include Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Rie Sakakibara is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Rie Sakakibara collaborates with scholars based in Japan, India and Germany. Rie Sakakibara's co-authors include Yuichi Ishikawa, Hironori Ninomiya, Sakae Okumura, Kentaro Inamura, Maki Kobayashi, Yusuke Yokouchi, Hiroko Nagano, Kimie Nomura, Makoto Nishio and Tomoko Shibutani and has published in prestigious journals such as The American Journal of Surgical Pathology, Oncotarget and Modern Pathology.

In The Last Decade

Rie Sakakibara

21 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rie Sakakibara Japan	10	376	264	115	114	67	27	528
Elisa Andrini Italy	11	287 0.8×	175 0.7×	102 0.9×	114 1.0×	63 0.9×	36	412
Jinluan Li China	14	361 1.0×	213 0.8×	76 0.7×	65 0.6×	89 1.3×	43	516
Jun Chul Chung South Korea	13	294 0.8×	183 0.7×	98 0.9×	64 0.6×	47 0.7×	32	545
Taisuke Tsuji Japan	11	240 0.6×	227 0.9×	73 0.6×	85 0.7×	28 0.4×	41	488
Kristin Kathleen Ancell United States	10	540 1.4×	155 0.6×	50 0.4×	98 0.9×	30 0.4×	16	653
Anika E. Adeni United States	10	560 1.5×	249 0.9×	52 0.5×	45 0.4×	37 0.6×	19	635
Alessandra Anna Prete Italy	9	388 1.0×	158 0.6×	42 0.4×	66 0.6×	144 2.1×	27	497
Noëlle Weingertner France	13	150 0.4×	192 0.7×	55 0.5×	94 0.8×	53 0.8×	42	400
Joanna Huszno Poland	11	193 0.5×	146 0.6×	40 0.3×	131 1.1×	102 1.5×	37	425
Hans‐Peter Allgaier Germany	13	204 0.5×	177 0.7×	146 1.3×	89 0.8×	51 0.8×	30	604

Countries citing papers authored by Rie Sakakibara

Since Specialization

Citations

This map shows the geographic impact of Rie Sakakibara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rie Sakakibara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rie Sakakibara more than expected).

Fields of papers citing papers by Rie Sakakibara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rie Sakakibara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rie Sakakibara. The network helps show where Rie Sakakibara may publish in the future.

Co-authorship network of co-authors of Rie Sakakibara

This figure shows the co-authorship network connecting the top 25 collaborators of Rie Sakakibara. A scholar is included among the top collaborators of Rie Sakakibara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rie Sakakibara. Rie Sakakibara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Honda, Takayuki, Iichiroh Onishi, Naoki Nishiyama, et al.. (2024). A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patients. ERJ Open Research. 11(1). 628–2024.

Kurihara, Yasuyuki, Takayuki Honda, Satoshi Endo, et al.. (2024). Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinoma. JTCVS Open. 20. 183–193. 1 indexed citations

Yamaguchi, Tetsuo, S. Mikoshiba, Kazuaki Sato, et al.. (2024). Relapsing bronchopneumonia due to community-associated methicillin-resistant Staphylococcus aureus: a case report. BMC Infectious Diseases. 24(1). 374–374. 1 indexed citations

Tateishi, Tomoya, Rie Sakakibara, Sho Shibata, et al.. (2023). COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease. Internal Medicine. 62(9). 1323–1328.

Maruyama, Soichi, Haruhiko Furusawa, Satoshi Endo, et al.. (2023). Pulmonary Artery Aneurysm in a Patient with Nontuberculous Mycobacteria Infection. Internal Medicine. 63(7). 989–992. 1 indexed citations

Aoki, Hikaru, Yasunari Miyazaki, Kota Yokoyama, et al.. (2023). Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum-intensity projection images. European Radiology. 34(1). 374–383. 9 indexed citations

Honda, Takayuki, Satoshi Endo, Kousuke Tanimoto, et al.. (2023). The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non‐small cell lung cancer. Cancer Medicine. 12(19). 19406–19413. 6 indexed citations

Sakakibara, Rie, Takayuki Honda, Sho Shibata, et al.. (2023). Tolerability of sotorasib for KRAS positive lung adenocarcinoma patient with pre-existing interstitial pneumonia; A case report. Respiratory Medicine Case Reports. 46. 101929–101929.

Sakashita, Hiroyuki, Ken Uchibori, Toshiharu Tsutsui, et al.. (2022). A phase II feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease (YLOG0114). Thoracic Cancer. 13(9). 1267–1275. 3 indexed citations

10.

Endo, Satoshi, et al.. (2022). Profile of metastatic lung cancer patients susceptible to development of thromboembolism during immunotherapy. Cancer Treatment and Research Communications. 31. 100547–100547. 2 indexed citations

11.

Okamoto, Tsukasa, Rie Sakakibara, Takayuki Honda, et al.. (2021). Predictors associated with clinical improvement of SARS-CoV-2 pneumonia. Journal of Infection and Chemotherapy. 27(6). 857–863.

12.

Sakakibara, Rie, et al.. (2021). Exploratory Factors Relevant to the Success of the Oncomine™ Dx Target Test<sup>®</sup>. Haigan. 61(7). 932–938. 1 indexed citations

13.

Okamoto, Tsukasa, Rie Sakakibara, Takayuki Honda, et al.. (2020). MuLBSTA score is a useful tool for predicting COVID-19 disease behavior. Journal of Infection and Chemotherapy. 27(2). 284–290. 9 indexed citations

14.

Ando, Takahiro, Naoki Nishiyama, Takayuki Honda, et al.. (2020). Optimization of Both the Diagnosis and Therapeutic Strategy Using Panel Testing for a Case of Pleural Metastasis of Sinus Carcinoma. Haigan. 60(4). 364–370.

15.

Nishikawa, Shingo, Rie Sakakibara, Ryo Ariyasu, et al.. (2018). EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer. Respiratory Medicine Case Reports. 24. 19–21. 12 indexed citations

16.

Takamatsu, Manabu, Yukiko Sato, Hiroko Nagano, et al.. (2018). Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas. Modern Pathology. 31(6). 923–933. 30 indexed citations

17.

Inamura, Kentaro, Yusuke Yokouchi, Maki Kobayashi, et al.. (2017). Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes. Oncotarget. 8(17). 28725–28735. 78 indexed citations

18.

Sakakibara, Rie, Kentaro Inamura, Yuichi Tambo, et al.. (2016). EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer. Clinical Lung Cancer. 18(5). 527–534.e1. 108 indexed citations

19.

Inamura, Kentaro, Yusuke Yokouchi, Maki Kobayashi, et al.. (2016). Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis. Lung Cancer. 103. 44–51. 77 indexed citations

20.

Inamura, Kentaro, Yusuke Yokouchi, Rie Sakakibara, et al.. (2016). Relationship of tumor PD-L1 expression withEGFRwild-type status and poor prognosis in lung adenocarcinoma. Japanese Journal of Clinical Oncology. 46(10). 935–941. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact